Section 37
Chapter 36,255

Transgenic overexpression of bone morphogenetic protein 11 propeptide in skeleton enhances bone formation

Li, Z.; Zeng, F.; Mitchell, A.D.; Kim, Y.S.; Wu, Z.; Yang, J.

Biochemical and Biophysical Research Communications 416(3-4): 289-292


ISSN/ISBN: 1090-2104
PMID: 22093826
DOI: 10.1016/j.bbrc.2011.11.019
Accession: 036254923

Download citation:  

Bone morphogenetic protein 11 (BMP11) is a key regulatory protein in skeletal development. BMP11 propeptide has been shown to antagonize GDF11 activity in vitro. To explore the role of BMP11 propeptide in skeletal formation in vivo, we generated transgenic mice with skeleton-specific overexpression of BMP11 propeptide cDNA. The mice showed a transformation of the seventh cervical vertebra into a thoracic vertebra in our previous report. Presently, further characterizations of the transgenic mice indicated that ossification in calvatia was dramatically enhanced in transgenic fetuses at 16.5 dpc in comparison with their wild-type littermates. At 10 weeks of age, bone mineral content and bone mineral density were significantly (P<0.05) higher in transgenic mice than that in their wild-type littermates based on dual energy X-ray absorptiometry analysis. The relative trabecular bone volume measured by histological analysis was dramatically increased in transgenic mice compared with their wild-type littermates. The enhanced bone formations in the transgenic mice appear to result from increase osteoblast activities as the expressions of four osteoblast markers - α1 type 1 collagen, osteocalcin, alkaline phosphatase and phex were significantly higher in transgenic fetuses than that in their wild-type littermates. These results suggest that over-expression of BMP11 propeptide stimulates bone formation by increasing osteoblast cell functions.

PDF emailed within 0-6 h: $19.90